Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Angiotensin Receptor Blockers on Insulin Resistance in End Stage Renal Disease Patients on Maintenance Hemodialysis
TCTR20130901001Phase 4Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Nov 2012
- Countries
- 1
01
Overview
Phase 4 trial in end-stage kidney disease (ESKD) and insulin resistance (IR), sponsored by Phramongkutklao Hospital. Primary endpoint: Change in insulin resistance. Started Nov 2012; status: completed.
02
Conditions
end-stage kidney disease (ESKD)insulin resistance (IR)
Beyond the preview
Go deeper on TCTR20130901001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20130901001.